Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (591-600 of 706) with videos related to

Pageof 71
Sort By:
European Journal of Heart Failure|January 10, 2025
Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trialAmbarish Pandey, Ahmed A Kolkailah, Darren K McGuire, et al.
Critical Pathways in Cardiology|August 31, 2010
Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosisWilliam E Boden, Gregory S Cherr, Kim A Eagle, et al.
American Heart Journal|December 5, 2016
On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT)Michael A Blazing, Robert P Giugliano, James A de Lemos, et al.
Circulation. Cardiovascular Interventions|November 3, 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|October 2, 2012
Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgeryChristoph Varenhorst, Ulrica Alström, Benjamin M Scirica, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 7, 2017
Soluble interleukin-13rα1: a circulating regulator of glucoseInbal Rachmin, Caitlin C O'Meara, Elisabeth M Ricci-Blair, et al.
Journal of Thrombosis and Thrombolysis|June 14, 2017
Platelet-related biomarkers and their response to inhibition with aspirin and p2y<sub>12</sub>-receptor antagonists in patients with acute coronary syndromeAngela Lowenstern, Robert F Storey, Megan Neely, et al.
JAMA|October 17, 2002
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarctionElizabeth M Mahoney, Claudine T Jurkovitz, Haitao Chu, et al.
Clinical Chemistry|December 10, 2016
Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary SyndromeDaniel Lindholm, Stefan K James, Maria Bertilsson, et al.
Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.
Pageof 71

Showing results (591-600 of 706) with videos related to

Sort By:
Pageof 71
European Journal of Heart Failure|January 10, 2025
Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trialAmbarish Pandey, Ahmed A Kolkailah, Darren K McGuire, et al.
Critical Pathways in Cardiology|August 31, 2010
Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosisWilliam E Boden, Gregory S Cherr, Kim A Eagle, et al.
American Heart Journal|December 5, 2016
On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT)Michael A Blazing, Robert P Giugliano, James A de Lemos, et al.
Circulation. Cardiovascular Interventions|November 3, 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|October 2, 2012
Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgeryChristoph Varenhorst, Ulrica Alström, Benjamin M Scirica, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 7, 2017
Soluble interleukin-13rα1: a circulating regulator of glucoseInbal Rachmin, Caitlin C O'Meara, Elisabeth M Ricci-Blair, et al.
Journal of Thrombosis and Thrombolysis|June 14, 2017
Platelet-related biomarkers and their response to inhibition with aspirin and p2y<sub>12</sub>-receptor antagonists in patients with acute coronary syndromeAngela Lowenstern, Robert F Storey, Megan Neely, et al.
JAMA|October 17, 2002
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarctionElizabeth M Mahoney, Claudine T Jurkovitz, Haitao Chu, et al.
Clinical Chemistry|December 10, 2016
Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary SyndromeDaniel Lindholm, Stefan K James, Maria Bertilsson, et al.
Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.
Pageof 71